Your browser doesn't support javascript.
loading
Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.
Buys, Heloise; Muloiwa, Rudzani; Bamford, Colleen; Eley, Brian.
Afiliação
  • Buys H; Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, Klipfontein Road, Cape Town, Rondebosch, 7700, South Africa. heloise.buys@uct.ac.za.
  • Muloiwa R; University of Cape Town, Cape Town, South Africa. heloise.buys@uct.ac.za.
  • Bamford C; Ambulatory and Emergency Paediatrics, Red Cross War Memorial Children's Hospital, Klipfontein Road, Cape Town, Rondebosch, 7700, South Africa. heloise.buys@uct.ac.za.
  • Eley B; Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, Klipfontein Road, Cape Town, Rondebosch, 7700, South Africa.
BMC Infect Dis ; 16(1): 570, 2016 Oct 17.
Article em En | MEDLINE | ID: mdl-27751185
ABSTRACT

BACKGROUND:

Klebsiella pneumoniae (KP) is a significant paediatric bloodstream pathogen in children. There is little data from Africa. In this study we describe the epidemiology of multi-drug resistant Klebsiella pneumoniae bloodstream infection (KPBSI) at Red Cross War Memorial Children's Hospital, Cape Town, South Africa.

METHODS:

We conducted a retrospective cross-sectional study of KPBSI from 1 January 2006 to 31 December 2011 using conventional descriptive and inferential statistical methods.

RESULTS:

Of 410 hospitalised children with laboratory confirmed KPBSI, 339 (83 %) were caused by extended-spectrum ß-lactamase (ESBL) producing isolates. The median age (IQR) was 5.0 (2-16) months, 212 (51.7 %) were male, 82 (20 %) were HIV-infected, and 241 (58.8 %) were moderately or severely underweight. The infection was hospital-acquired or healthcare-associated in 389 (95 %) children and community-acquired in 21 (5 %) children. Significant risk factors for ESBL-KPBSI included cephalosporin exposure in the 12 months prior to the KPBSI, adjusted risk ratio (aRR) 1.18 (95 % CI 1.06-1.31); HIV infection, aRR 1.14 (1.04-1.25), and intravenous infusions for more than 3 days before the KPBSI, aRR 1.15 (95 % CI 1.04-1.28). A total of 109 (26.6 %) children died within 30 days of the KPBSI, their median age was four (IQR 1-11) months. The median (IQR) time between KPBSI and death was three (1-9) days. HIV-infection, aRR 2.44(95 % CI 1.59-3.74); skin erosions at the time of KPBSI, aRR 2.15 (95 % CI 1.54-3.00); being in PICU at the time of the KPBSI, aRR 1.64 (95 % CI 1.03-2.61) or needing PICU admission after developing KPBSI, aRR 1.72 (95 % CI 1.10-2.70) were significant risk factors for death.

CONCLUSION:

ESBL-producing KP is an important cause of laboratory confirmed bloodstream infection in hospitalised children and is associated with high mortality.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Klebsiella / Bacteriemia / Klebsiella pneumoniae Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Klebsiella / Bacteriemia / Klebsiella pneumoniae Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article